Copyright Reports & Markets. All rights reserved.

Global Antiemetic Drugs Sales Market Report 2021

Request for Sample of this report
Buy now

1 Antiemetic Drugs Market Overview

  • 1.1 Antiemetic Drugs Product Scope
  • 1.2 Antiemetic Drugs Segment by Type
    • 1.2.1 Global Antiemetic Drugs Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Dopamine Antagonist
    • 1.2.3 5-HT-3 Receptor Antagonist
    • 1.2.4 NK1 Receptor Antagonist
    • 1.2.5 Cannabinoid Receptor Antagonist
  • 1.3 Antiemetic Drugs Segment by Application
    • 1.3.1 Global Antiemetic Drugs Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Chemotherapy
    • 1.3.3 Gastroenteritis
    • 1.3.4 Surgery
  • 1.4 Antiemetic Drugs Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Antiemetic Drugs Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Antiemetic Drugs Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Antiemetic Drugs Price Trends (2016-2027)

2 Antiemetic Drugs Estimates and Forecasts by Region

  • 2.1 Global Antiemetic Drugs Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Antiemetic Drugs Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Antiemetic Drugs Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Antiemetic Drugs Revenue Market Share by Region (2016-2021)
  • 2.3 Global Antiemetic Drugs Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Antiemetic Drugs Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Antiemetic Drugs Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Antiemetic Drugs Estimates and Projections (2016-2027)
    • 2.4.2 Europe Antiemetic Drugs Estimates and Projections (2016-2027)
    • 2.4.3 China Antiemetic Drugs Estimates and Projections (2016-2027)
    • 2.4.4 Japan Antiemetic Drugs Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Antiemetic Drugs Estimates and Projections (2016-2027)
    • 2.4.6 India Antiemetic Drugs Estimates and Projections (2016-2027)

3 Global Antiemetic Drugs Competition Landscape by Players

  • 3.1 Global Top Antiemetic Drugs Players by Sales (2016-2021)
  • 3.2 Global Top Antiemetic Drugs Players by Revenue (2016-2021)
  • 3.3 Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2020)
  • 3.4 Global Antiemetic Drugs Average Price by Company (2016-2021)
  • 3.5 Manufacturers Antiemetic Drugs Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Antiemetic Drugs Market Size by Type

  • 4.1 Global Antiemetic Drugs Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Antiemetic Drugs Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Antiemetic Drugs Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Antiemetic Drugs Price by Type (2016-2021)
  • 4.2 Global Antiemetic Drugs Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Antiemetic Drugs Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Antiemetic Drugs Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Antiemetic Drugs Price Forecast by Type (2022-2027)

5 Global Antiemetic Drugs Market Size by Application

  • 5.1 Global Antiemetic Drugs Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Antiemetic Drugs Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Antiemetic Drugs Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Antiemetic Drugs Price by Application (2016-2021)
  • 5.2 Global Antiemetic Drugs Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Antiemetic Drugs Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Antiemetic Drugs Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Antiemetic Drugs Price Forecast by Application (2022-2027)

6 North America Antiemetic Drugs Market Facts & Figures

  • 6.1 North America Antiemetic Drugs Sales by Company
    • 6.1.1 North America Antiemetic Drugs Sales by Company (2016-2021)
    • 6.1.2 North America Antiemetic Drugs Revenue by Company (2016-2021)
  • 6.2 North America Antiemetic Drugs Sales Breakdown by Type
    • 6.2.1 North America Antiemetic Drugs Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Antiemetic Drugs Sales Breakdown by Type (2022-2027)
  • 6.3 North America Antiemetic Drugs Sales Breakdown by Application
    • 6.3.1 North America Antiemetic Drugs Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Antiemetic Drugs Sales Breakdown by Application (2022-2027)

7 Europe Antiemetic Drugs Market Facts & Figures

  • 7.1 Europe Antiemetic Drugs Sales by Company
    • 7.1.1 Europe Antiemetic Drugs Sales by Company (2016-2021)
    • 7.1.2 Europe Antiemetic Drugs Revenue by Company (2016-2021)
  • 7.2 Europe Antiemetic Drugs Sales Breakdown by Type
    • 7.2.1 Europe Antiemetic Drugs Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Antiemetic Drugs Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Antiemetic Drugs Sales Breakdown by Application
    • 7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)

8 China Antiemetic Drugs Market Facts & Figures

  • 8.1 China Antiemetic Drugs Sales by Company
    • 8.1.1 China Antiemetic Drugs Sales by Company (2016-2021)
    • 8.1.2 China Antiemetic Drugs Revenue by Company (2016-2021)
  • 8.2 China Antiemetic Drugs Sales Breakdown by Type
    • 8.2.1 China Antiemetic Drugs Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Antiemetic Drugs Sales Breakdown by Type (2022-2027)
  • 8.3 China Antiemetic Drugs Sales Breakdown by Application
    • 8.3.1 China 164 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 164 Sales Breakdown by Application (2022-2027)

9 Japan Antiemetic Drugs Market Facts & Figures

  • 9.1 Japan Antiemetic Drugs Sales by Company
    • 9.1.1 Japan Antiemetic Drugs Sales by Company (2016-2021)
    • 9.1.2 Japan Antiemetic Drugs Revenue by Company (2016-2021)
  • 9.2 Japan Antiemetic Drugs Sales Breakdown by Type
    • 9.2.1 Japan Antiemetic Drugs Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Antiemetic Drugs Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Antiemetic Drugs Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Antiemetic Drugs Market Facts & Figures

  • 10.1 Southeast Asia Antiemetic Drugs Sales by Company
    • 10.1.1 Southeast Asia Antiemetic Drugs Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Antiemetic Drugs Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Antiemetic Drugs Sales Breakdown by Type
    • 10.2.1 Southeast Asia Antiemetic Drugs Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Antiemetic Drugs Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Antiemetic Drugs Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Antiemetic Drugs Market Facts & Figures

  • 11.1 India Antiemetic Drugs Sales by Company
    • 11.1.1 India Antiemetic Drugs Sales by Company (2016-2021)
    • 11.1.2 India Antiemetic Drugs Revenue by Company (2016-2021)
  • 11.2 India Antiemetic Drugs Sales Breakdown by Type
    • 11.2.1 India Antiemetic Drugs Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Antiemetic Drugs Sales Breakdown by Type (2022-2027)
  • 11.3 India Antiemetic Drugs Sales Breakdown by Application
    • 11.3.1 India Antiemetic Drugs Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Antiemetic Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Antiemetic Drugs Business

  • 12.1 GlaxoSmithKline
    • 12.1.1 GlaxoSmithKline Corporation Information
    • 12.1.2 GlaxoSmithKline Business Overview
    • 12.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 GlaxoSmithKline Antiemetic Drugs Products Offered
    • 12.1.5 GlaxoSmithKline Recent Development
  • 12.2 Johnson & Johnson
    • 12.2.1 Johnson & Johnson Corporation Information
    • 12.2.2 Johnson & Johnson Business Overview
    • 12.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Johnson & Johnson Antiemetic Drugs Products Offered
    • 12.2.5 Johnson & Johnson Recent Development
  • 12.3 Pfizer
    • 12.3.1 Pfizer Corporation Information
    • 12.3.2 Pfizer Business Overview
    • 12.3.3 Pfizer Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Pfizer Antiemetic Drugs Products Offered
    • 12.3.5 Pfizer Recent Development
  • 12.4 Sanofi
    • 12.4.1 Sanofi Corporation Information
    • 12.4.2 Sanofi Business Overview
    • 12.4.3 Sanofi Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Sanofi Antiemetic Drugs Products Offered
    • 12.4.5 Sanofi Recent Development
  • 12.5 Abbott
    • 12.5.1 Abbott Corporation Information
    • 12.5.2 Abbott Business Overview
    • 12.5.3 Abbott Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Abbott Antiemetic Drugs Products Offered
    • 12.5.5 Abbott Recent Development
  • 12.6 Bristol-Myers Squibb
    • 12.6.1 Bristol-Myers Squibb Corporation Information
    • 12.6.2 Bristol-Myers Squibb Business Overview
    • 12.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Bristol-Myers Squibb Antiemetic Drugs Products Offered
    • 12.6.5 Bristol-Myers Squibb Recent Development
  • 12.7 Cipla
    • 12.7.1 Cipla Corporation Information
    • 12.7.2 Cipla Business Overview
    • 12.7.3 Cipla Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Cipla Antiemetic Drugs Products Offered
    • 12.7.5 Cipla Recent Development
  • 12.8 Eisai
    • 12.8.1 Eisai Corporation Information
    • 12.8.2 Eisai Business Overview
    • 12.8.3 Eisai Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Eisai Antiemetic Drugs Products Offered
    • 12.8.5 Eisai Recent Development
  • 12.9 Eli Lilly
    • 12.9.1 Eli Lilly Corporation Information
    • 12.9.2 Eli Lilly Business Overview
    • 12.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Eli Lilly Antiemetic Drugs Products Offered
    • 12.9.5 Eli Lilly Recent Development
  • 12.10 Glenmark
    • 12.10.1 Glenmark Corporation Information
    • 12.10.2 Glenmark Business Overview
    • 12.10.3 Glenmark Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Glenmark Antiemetic Drugs Products Offered
    • 12.10.5 Glenmark Recent Development
  • 12.11 Helsinn Healthcare
    • 12.11.1 Helsinn Healthcare Corporation Information
    • 12.11.2 Helsinn Healthcare Business Overview
    • 12.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Helsinn Healthcare Antiemetic Drugs Products Offered
    • 12.11.5 Helsinn Healthcare Recent Development
  • 12.12 Heron Therapeutics
    • 12.12.1 Heron Therapeutics Corporation Information
    • 12.12.2 Heron Therapeutics Business Overview
    • 12.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Heron Therapeutics Antiemetic Drugs Products Offered
    • 12.12.5 Heron Therapeutics Recent Development
  • 12.13 IPCA Laboratories
    • 12.13.1 IPCA Laboratories Corporation Information
    • 12.13.2 IPCA Laboratories Business Overview
    • 12.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 IPCA Laboratories Antiemetic Drugs Products Offered
    • 12.13.5 IPCA Laboratories Recent Development
  • 12.14 Lupin
    • 12.14.1 Lupin Corporation Information
    • 12.14.2 Lupin Business Overview
    • 12.14.3 Lupin Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Lupin Antiemetic Drugs Products Offered
    • 12.14.5 Lupin Recent Development
  • 12.15 Merck
    • 12.15.1 Merck Corporation Information
    • 12.15.2 Merck Business Overview
    • 12.15.3 Merck Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Merck Antiemetic Drugs Products Offered
    • 12.15.5 Merck Recent Development
  • 12.16 Novartis
    • 12.16.1 Novartis Corporation Information
    • 12.16.2 Novartis Business Overview
    • 12.16.3 Novartis Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Novartis Antiemetic Drugs Products Offered
    • 12.16.5 Novartis Recent Development
  • 12.17 RedHill
    • 12.17.1 RedHill Corporation Information
    • 12.17.2 RedHill Business Overview
    • 12.17.3 RedHill Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 RedHill Antiemetic Drugs Products Offered
    • 12.17.5 RedHill Recent Development
  • 12.18 Sun Pharmaceutical Industries
    • 12.18.1 Sun Pharmaceutical Industries Corporation Information
    • 12.18.2 Sun Pharmaceutical Industries Business Overview
    • 12.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Products Offered
    • 12.18.5 Sun Pharmaceutical Industries Recent Development
  • 12.19 Takeda Pharmaceutical
    • 12.19.1 Takeda Pharmaceutical Corporation Information
    • 12.19.2 Takeda Pharmaceutical Business Overview
    • 12.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 Takeda Pharmaceutical Antiemetic Drugs Products Offered
    • 12.19.5 Takeda Pharmaceutical Recent Development

13 Antiemetic Drugs Manufacturing Cost Analysis

  • 13.1 Antiemetic Drugs Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Antiemetic Drugs
  • 13.4 Antiemetic Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Antiemetic Drugs Distributors List
  • 14.3 Antiemetic Drugs Customers

15 Market Dynamics

  • 15.1 Antiemetic Drugs Market Trends
  • 15.2 Antiemetic Drugs Drivers
  • 15.3 Antiemetic Drugs Market Challenges
  • 15.4 Antiemetic Drugs Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Antiemetic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiemetic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Dopamine Antagonist
    5-HT-3 Receptor Antagonist
    NK1 Receptor Antagonist
    Cannabinoid Receptor Antagonist

    Segment by Application
    Chemotherapy
    Gastroenteritis
    Surgery

    The Antiemetic Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Antiemetic Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    GlaxoSmithKline
    Johnson & Johnson
    Pfizer
    Sanofi
    Abbott
    Bristol-Myers Squibb
    Cipla
    Eisai
    Eli Lilly
    Glenmark
    Helsinn Healthcare
    Heron Therapeutics
    IPCA Laboratories
    Lupin
    Merck
    Novartis
    RedHill
    Sun Pharmaceutical Industries
    Takeda Pharmaceutical

    Buy now